Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 26 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 8017151

    Amphiphilic polymer-protein conjugates and methods of use thereof

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted
  2. US 8012976

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  3. US 8013015

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  4. US 7994306

    Methods of treating cancer using siRNA molecules directed against CD24

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted
  5. US 7985428

    Method and composition for modulation of systemic inflammatory responses syndrome (SIRS)

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted
  6. US 7985581

    Multiple RNA polymerase III promoter expression constructs

    Alnylam Pharmaceuticals, Inc. · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted
  7. US 7985836

    Antimicrobial peptides and methods of identifying the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted
  8. US 7968749

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  9. US 7960133

    Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

    The Board of Regents of the University of Texas System · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  10. US 7951805

    Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

    Xenon Pharmaceuticals Inc. · Granted May 31, 2011 · Expires May 26, 2031

    granted
  11. US 7943161

    Contrast agent coated medical device

    Cook Regentec LLC · Granted May 17, 2011 · Expires May 12, 2031

    granted
  12. US 7919496

    Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted
  13. US 7855233

    Citrate salt of Rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  14. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted
  15. US 7829712

    Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

    Xenon Pharmaceuticals Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  16. US 7825096

    O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  17. US 7815942

    Rasagiline formulations of improved content uniformity

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  18. US 7816075

    Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  19. US 7807463

    Pre-transplant accommodated organs resistant to anti-donor immunity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted
  20. CA 2754902

    COMPOSES D'ACIDE GRAS ESSENTIEL

    AMARIN NEUROSCIENCE LTD [GB] · Granted Sep 16, 2010 · Expires Sep 11, 2030

    granted
  21. US 7790738

    Methods of treating and preventing AIDS using of COX-2 inhibitors

    Lauras AS · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted
  22. US 7776883

    Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted
  23. US 7767677

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  24. US 7763255

    Therapeutic uses of Dunaliella powder

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted